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ABSTRACT
Objective: To translate and cross-culturally adapt the Brief Illness Perception Questionnaire (BIPQ) and 
the Beliefs about Medicines Questionnaire (BMQ) into Vietnamese.
Methods: We followed the guideline by Beaton et al. (2000 & 2007). Stage I: two translators (informed 
and uninformed) translated the questionnaires. Stage II: the translations were synthesized. Stage III: back 
translation was performed by two translators fluent in both Vietnamese and English but naïve to the 
outcome measurement. Stage IV: seven experts reached consensus on the pre-final Vietnamese version 
(BIPQ-V and BMQ-V). Stage V: field test of the questionnaires on 16 twelve-year-old students and 31 
Vietnamese patients. In addition, we determined the internal consistency and test-retest reliability of the 
questionnaires in 34 Vietnamese patients with acute coronary syndrome.  
Results: All experts agreed that there was semantic, idiomatic, experiential, and conceptual equivalence 
between the original and pre-final Vietnamese versions of the BIPQ and BMQ. Cronbach’s alpha 
coefficients of the internal consistency were acceptable for the BMQ-V Specific-Necessity (0.64), BMQ-V 
Specific-Concerns (0.62), and BMQ-V General-Harm (0.60), with the exception of BMQ-V General-Overuse 
(0.27). Intra-class correlation coefficients of the test-retest reliability was acceptable for the subscales of 
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BMQ-V (range: 0.77-0.86), and BIPQ-V items (range: 0.62-0.85) with the exception of BIPQ-V 1 (0.44, 95% 
CI -014-0.72) and BIPQ-V 4 (0.57, 95% CI 0.22-0.81).
Conclusions: The Vietnamese version of BIPQ and BMQ are reliable tools to assess illness perceptions and 
beliefs about medicines of patients with acute coronary syndrome. Psychometric properties of these 
questionnaires should be tested in different patient populations. 
Keywords: Translation, cross-cultural adaptation, illness perception, beliefs about medicines, Vietnamese
INTRODUCTION
Approximately half of all medicines prescribed for chronic conditions are not used as intended [1, 2]. 
Nonadherence to medicines has a considerable impact on patients' health outcomes (increasing morbidity 
and mortality) and the healthcare system (increasing use of services and hospital readmissions) [3, 4]. 
Many factors influence adherence, such as patient characteristics, medication class, physical 
comorbidities, pharmacy co-payments or medication costs, health/medication beliefs and provider 
communication [5]. 
Recent systematic reviews and meta-analyses showed a significant association between 
medication adherence and illness perception [6] and beliefs about medicines [7, 8]. Previous studies have 
also investigated associations between patients' outcomes (behavioral, quality-of-life, or physical health) 
and patients' illness perceptions [6], beliefs about medicines [7, 8], or medication adherence [9]. To assess 
these aspects, the Brief Illness Perception Questionnaire (BIPQ)  [10] and the Beliefs about Medicines 
Questionnaire (BMQ)  [11] are widely used in different languages and illness populations [6, 7, 12]. Both 
questionnaires were developed in English-speaking countries and have been translated and validated in 
different cultures [13-16].  
To gain insight into patients' illness perceptions and beliefs about medicines, being able to assess 
these aspects across countries, translation and cross-cultural adaption of these questionnaires are needed 
[17, 18], but validated Vietnamese versions of the BIPQ and BMQ seem to be absent so far. Therefore we 
aimed to translate and cross-culturally adapt the BIPQ and BMQ into Vietnamese.
METHODS
We conducted the study in Can Tho city, Vietnam between September 2014 and June 2015. Participants 
involving in the study comprised healthcare and English language professionals, twelve-year-old students 
and patients with acute coronary syndrome (ACS) (Appendix A). The study was approved by the 
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City, Vietnam. Informed consent was obtained from all participants.   
The BIPQ is a 9-item questionnaire designed to assess dimensions of illness perception. Five items 
assess cognitive illness representations: consequences (BIPQ 1), timeline (BIPQ 2), personal control (BIPQ 
3), treatment control (BIPQ 4), and identity (BIPQ 5). Two items assess emotional representations: 
concern (BIPQ 6) and emotions (BIPQ 8). One item assesses illness comprehensibility (BIPQ 7). Responses 
are scored on a scale ranging from 0 to 10 [10]. The BMQ is an 18-item questionnaire designed to assess 
the cognitive representation of medication. It comprises two sections. The BMQ Specific assesses 
patients’ beliefs about the particular medications prescribed for them, comprising two subscales: Specific 
Necessity and Specific Concerns. The BMQ General assesses more general beliefs about medicines as a 
whole, comprising two subscales: General Harm and General Overuse. Each item of the BMQ subscales is 
scored on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree) [11]. 
The process of translation and cross-cultural adaptation of the BIPQ and BMQ is summarized in 
Figure 1. We followed the five stages of the guideline by Beaton et al. (2000 & 2007) [17, 18]:
Stage I – Initial Translation: The BIPQ and BMQ were independently translated from English into 
Vietnamese by two professionals fluent in English. One had a medical background and was aware of the 
study objective (informed translator), and the other had no medical background and was unaware of the 
study objective (uninformed translator). They produced two translations called T1 and T2.
Stage II – Synthesis of these Translations: The two translators synthesized the T1 and T2 
translations and produced a T1&2 translation.
Stage III – Back Translation: Two back translators (fluent in both Vietnamese and English and 
without medical background) independently back-translated the T1&2 translation from Vietnamese into 
English and produced the BT1 and BT2 translations. The back translators were unaware of the original 
version of the BIPQ and BMQ and the study objective. Both were native Vietnamese speakers and 
proficient in English.
Stage IV – Expert Committee Review: The committee, consisting of seven experts (two 
methodologists, three translators, and two physicians), compared all versions of translations produced in 
the previous steps with the original version and agreed on the pre-final version of the BIPQ and BMQ in 
Vietnamese (called BIPQ-V and BMQ-V). The committee evaluated the equivalence between the original 
and the pre-final version in four aspects: semantic, idiomatic, experiential, and conceptual. 
Stage V – Test of the Pre-Final Version: The pre-final version of the three questionnaires was 
tested on 16 twelve-year-old students of a secondary school in Vietnam and 31 patients with a history of 
acute coronary syndrome (ACS) (Appendix A). Participants were asked what they thought each 
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items were understood. Each interview required 20-30 minute to complete. All expert committee 
members reached consensus and produced the final version of the BIPQ-V and BMQ-V. 
Stage VI – Testing Reliability of the Final Version: Consequently, we determined the reliability of 
the BIPQ-V and BMQ-V in 34 other patients with ACS and no cognitive impairment (with the score of the 
mini mental state examination score less than 18) (Appendix A). Three interviews were conducted with 
each included patient. The first interview was during hospitalization (using the BIPQ-V and BMQ-V), and 
the second one month after discharge (using the BIPQ-V and BMQ-V). The first interview took place in the 
study hospitals, and the second and the third in patients’ homes. Each interview required 10-15 minutes 
to complete. We evaluated the internal consistency of the BIPQ-V and BMQ-V based on the first 
interview, and the test-retest reliability of the BIPQ-V and BMQ-V based on the first and second interview. 
The interval between the test and retest measures was one month. DNQ conducted all interviews at this 
stage. 
Descriptive statistics were used to describe demographic and disease characteristics of the 
patients and their questionnaire scores. Percentages and frequencies were used for the categorical 
variables. Means and standard deviations were calculated for the continuous variables. The internal 
consistency for the BMQ-V Specific Necessity, BMQ-V Specific Concerns, BMQ-V General Overuse and 
BMQ-V General Harm was assessed by calculating Cronbach’s alpha coefficients. Cronbach’s alpha 
coefficients above 0.5 are generally considered acceptable. The corrected item-total correlation was also 
reported along with the alpha for each question [19]. The corrected item-total correlation coefficient 
value of < 0.2 indicates that the item contributes very little to the homogeneity of the scale [20]. The test-
retest reliability of the BMQ-V Specific Necessity, BMQ-V Specific Concerns, BMQ-V General Overuse, 
BMQ-V General Harm, and the first eight items of BIPQ-V, was assessed using the intraclass correlation 
coefficients (ICCs) with 95% confidence interval (CI) of absolute agreement based on a two-way mixed 
model. ICCs above 0.60 are generally considered acceptable [21]. The significance level was set at p-values 
of 0.05 or less. All analyses were done in SPSS version 24.0.
RESULTS
Discrepancies between original and translations that were observed during the stages I to IV are 
summarised in Table 1. At stage IV, the expert panel agreed that there was semantic, idiomatic, 
experiential, and conceptual equivalence between original and pre-final translation version of the BIPQ 
and BMQ.
At stage V, we interviewed 16 twelve-year-old students (4 males, 12 females) and 31 patients with 
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items were understood by an average of 99.3% of students and 96.4% of patients. The BMQ-V items were 
understood by an average of 99.3% students and 98.7% patients. The expert committee produced the 
final version of the BIPQ-V and BMQ-V (Appendix C).
At stage VI, 34 patients were included. Patients' mean ± SD age was 60.3 ± 7.7 years, 58.8% were 
males, and 85.3% had social health insurance. 97.1% of patients were Kinh ethnic, 82.4% were non-
smokers, 52.9% had ≥ 3 comorbidities, 52.9% were financially dependent, 97.1% were independent of a 
caregiver. The level of education was <6th grade in 67.6%, and the MMSE score ≥24 in 88.2%.  
Cronbach’s alpha coefficients of the internal consistency were acceptable for the BMQ-V Specific 
Necessity (0.64), BMQ-V Specific Concerns (0.62), and BMQ-V General Harm (0.60), with the exception of 
BMQ-V General Overuse (0.27). The corrected item-total correlation coefficients' ranges were -0.09; 0.77 
for the BMQ-V Specific Necessity, -0.06; 0.57 for the BMQ-V Specific Concerns, 0.01; 0.22 for the BMQ-V 
General Overuse, and 0.11; 0.52 for the BMQ-V General Harm (Table 2). 
The ICCs of the test-retest reliability ranged between 0.44 (95% CI -0.14-0.72) and 0.85 (95% CI 
0.70-0.93) for the eight items of BIPQ-V, and between 0.77 (95% CI 0.54-0.88) and 0.86 (95% CI 0.72-0.93) 
for the subscales of BMQ-V. The test-retest reliability was acceptable for BMQ-V Specific Necessity, BMQ-
V Specific Concerns, BMQ-V General Overuse, BMQ-V General Harm, and BIPQ-V items, but not 
acceptable for BIPQ-V 1 and BIPQ-V 4 (Table 3).
DISCUSSION
The BIPQ-V and BMQ-V were translated and cross-culturally adapted from the original English versions 
BIPQ and BMQ. Our results suggest that the three questionnaires are reliable tools for assessing illness 
perception, beliefs about medicines and medication adherence in Vietnamese patients with ACS. 
The results of test-retest reliability were acceptable for individual items of the BIPQ-V, with the 
exception of the items measuring consequences and treatment control (BIPQ-V 1 and BIPQ-V 4). The 
reason for low test-retest reliability of these two items was probably changes in patients' perceptions due 
to experiencing treatment effects in the time after discharge between hospitalization (first measure) and 
one month after discharge (the second measure). This should be considered in future studies.
A number of BMQ items were difficult to translate. For instance, the word "mystery" in the BMQ 8 
item (My medicines are a mystery to me), that is "điều huyền bí" in the Vietnamese language refers to 
something that is difficult or impossible to understand or explain, or to something happening that cannot 
be explained scientifically. Researchers in Portugal [22] and Scandinavian countries [14] reported similar 
problems with this statement. Subscales of the BMQ-V had acceptable internal consistency (Cronbach's 
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consistency of the BMQ-V General Overuse (Cronbach's alpha = 0.27) which was lower than that of the 
original BMQ General Overuse (Cronbach's alpha = 0.60 to 0.80) [11]. There were three out of four 
questionnaire items of the BMQ-V General Overuse with the corrected item-total correlation coefficient 
values of < 0.2. These items contributed very little to the homogeneity of the subscale. 
The cross-cultural adaptation of a health assessment scale in a new country, culture and/or 
language should reach equivalence between the original source and target languages [17, 18]. A 
systematic review by Uysal-Bozkir et al.  [23] showed that cross-cultural adaptations were insufficient, and 
psychometric properties of many translated health assessment scales were still unknown. There are many 
different international guidelines for cross-cultural adaptation that could be used [23, 24]. The guideline 
by Beaton et al.  [17, 18] has been recommended by the Institute for Work & Health and widely used [16, 
25-28]. We followed all its stages for translation and cross-cultural adaptation and in addition assessed 
the cognitive status of participants prior to inclusion. 
Several limitations should be considered in the present study. First, this study was performed by 
lecturers of pharmacy, medicine and English. We are not linguists, and therefore rely on our scientific 
research background and interest in the Vietnamese language. Second, as the paper is about illness 
perceptions and medicine beliefs a qualitative study conducted in advance would have been needed. Such 
perceptions and beliefs may be very different in the Vietnamese culture compared to other cultures 
where the instruments were developed and used. The considerable differences between two countries 
and cultures might contribute to moderate internal consistency of the scales. The other limitation is the 
small number of patients at the stage of testing reliability of the questionnaires. The weakness could have 
an impact on the findings. Further studies with more patients to validate these questionnaires should be 
conducted. This is just the first step to have the Vietnamese version of the scales; we suggest that more 
studies be conducted to test and confirm the psychometric properties of these scales in different patient 
groups and healthcare settings.
The findings support use of the three questionnaires in Vietnam. The country is facing a high 
burden of acute coronary syndrome as well as other chronic conditions. More research on the 
psychometric properties of the BIPQ-V and BMQ-V in Vietnamese patients with ACS or other chronic 
conditions is needed. Further work should also be carried out to identify the association between illness 
perception, beliefs about medicine, medication adherence and patients' health outcomes among 
Vietnamese patients as previous studies in other countries [29-34].
CONCLUSION
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medicines of patients with ACS. Further studies are needed to validate the psychometric properties of 
these questionnaires in patients with different chronic conditions in different clinical settings.
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Table 1. Report of main discrepancies between original and Vietnamese/back-translated version of the 
three questionnaires and solutions during stages I to IV
Questionnaire item Discrepancy Solution
BIPQ 5: How much do you 
experience symptoms from 
your illness?
There is no equivalent word of 
“experience” in Vietnamese in 
the context.
We translated “experience” into 
“be aware of” in Vietnamese.
BMQ 8: My medicines are a 
mystery to me.
There is no equivalent word of 
“mystery” in Vietnamese in the 
context.
We translated “mystery” into 
“something is not fully 
understood” in Vietnamese.
BMQ 11: Doctors use too 
many medicines.
It might be misunderstood as 
“Doctors use too many 
medicines for themselves”.
We specified “doctors use too 
many medicines for patients” and 
not for the other objects and not 
for themselves (doctors).
BMQ 12: Natural remedies 
are safer than medicines.
The word “medicine” is a term 
with broad meaning, probably 
something to cure an illness.
We specify that it is similar to 
“synthesized medicines” or 
"modern medicines" to be 
distinguished from “natural 
remedies”.
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BMQ-V Specific-Necessity: Cronbach’s alpha was 0.64 for the total subscale
BMQ-V 1 4.87 ± 0.44 0.45 0.57
BMQ-V 2 4.88 ± 0.48 0.72 0.45
BMQ-V 3 4.79 ± 0.59 0.62 0.47
BMQ-V 4 4.85 ± 0.50 0.77 0.42
BMQ-V 5 4.79 ± 0.85 -0.09 0.89
BMQ-V Specific-Concerns: Cronbach’s alpha was 0.62 for the total subscale
BMQ-V 6 2.26 ± 1.86 0.33 0.59
BMQ-V 7 3.15 ± 1.86 0.43 0.54
BMQ-V 8 4.85 ± 0.70 -0.06 0.68
BMQ-V 9 3.26 ± 1.94 0.57 0.45
BMQ-V 10 3.35 ± 1.92 0.51 0.49
BMQ-V General-Overuse: Cronbach’s alpha was 0.27 for the total subscale
BMQ-V 11 2.21 ± 1.57 0.15 0.19
BMQ-V 12 3.21 ± 1.77 0.18 0.15
BMQ-V 13 4.09 ± 1.29 0.01 0.35
BMQ-V 14 3.88 ± 1.12 0.22 0.14
BMQ-V General-Harm: Cronbach’s alpha was 0.603 for the total subscale
BMQ-V 15 1.97 ± 1.53 0.11 0.70
BMQ-V 16 2.59 ± 1.89 0.45 0.48
BMQ-V 17 2.32 ± 1.75 0.52 0.43
BMQ-V 18 2.79 ± 1.94 0.48 0.45
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Mean ± SD ICC 95% CI p-value
BIPQ-V 1 5.71 ± 2.81 5.76 ± 2.88 0.44 -0.14 - 0.72 0.055
BIPQ-V 2 9.00 ± 2.61 9.53 ± 1.91 0.84 0.69 - 0.92 <0.001
BIPQ-V 3 5.18 ± 3.03 5.41 ± 3.15 0.78 0.55 - 0.89 <0.001
BIPQ-V 4 7.21 ± 1.87 6.97 ± 2.18 0.57 0.13 - 0.78 0.010
BIPQ-V 5 3.21 ± 3.08 3.15 ± 2.72 0.62 0.22 - 0.81 0.004
BIPQ-V 6 7.44 ± 3.11 6.85 ± 3.66 0.85 0.70 - 0.93 <0.001
BIPQ-V 7 6.29 ± 3.05 4.97 ± 4.00 0.64 0.29 - 0.82 0.001
BIPQ-V 8 3.50 ± 3.54 4.26 ± 3.73 0.63 0.27 - 0.82 0.003
BMQ-V Specific-Necessity 24.18 ± 1.88 24.35 ± 2.20 0.86 0.71 - 0.93 <0.001
BMQ-V Specific-Concerns 16.88 ± 5.44 17.44 ± 5.41 0.77 0.54 - 0.88 <0.001
BMQ-V General-Overuse 13.38 ± 3.27 14.29 ± 3.08 0.81 0.62 - 091 <0.001
BMQ-V General-Harm 9.68 ± 4.82 9.79 ± 4.54 0.86 0.72 - 0.93 <0.001
Abbreviations: BIPQ-V, Brief Illness Perception Questionnaire - Vietnamese version; BMQ-V, Beliefs about 
Medicines Questionnaire - Vietnamese version; ICC, intra-class correlation coefficient; SD, standard 
deviation.
aUsing BIPQ and BMQ during hospitalization; 
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Legend to Figure (In separate file)
Figure 1. Process of translation and cross-cultural adaptation
Abbreviations: BIPQ, Brief Illness Perception Questionnaire; BIPQ-V, Brief Illness Perception 
Questionnaire - Vietnamese version; BMQ, Beliefs about Medicines Questionnaire; BMQ-V, Beliefs about 
Medicines Questionnaire - Vietnamese version.
Legends to APPENDICES (in separate file)
Appendix A. Characteristics of participants in the study
Appendix B. Understanding items of the pre-final version of the BIPQ and BMQ in twelve-year-old 
students and pilot patients
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APPENDICES A-C 
 






There were nine professionals involving in six stages of the study: TN and 
STP were clinical pharmacists and lecturers at Can Tho University of 
Medicine and Pharmacy, Can Tho City, Vietnam; HTKC, KKL, and TTP 
were medical doctors and lecturers at Can Tho University of Medicine and 
Pharmacy; DNQ was the last year pharmacy student at Can Tho University of 
Medicine and Pharmacy; SXA was an English language lecturer at Can Tho 
University of Medicine and Pharmacy; THN was a clinical pharmacist and 
lecturer of University of Medicine and Pharmacy, Ho Chi Minh City, 
Vietnam; KT was a clinical pharmacist and lecturer at University of 
Groningen, Groningen City, The Netherlands. We also invited two English 





At stage V, we interviewed at least 15 twelve-year-old students at a secondary 
school in Vietnam in November 2014.   
 
Pilot patients At stage V, the pre-final version of the BIPQ and BMQ in Vietnamese were 
administered to at least 30 patients with a history of acute coronary syndrome 
at the central hospital in Can Tho in December 2014. All patients were asked 
for the verbal informed consent before the interview.  
 
Patients for testing 
reliability 
At stage VI, we recruited all eligible patients discharged from two hospitals 
(one central and one provincial) in Can Tho between January and April 2015 
and followed them for two months after discharge. The study ended in June 
2015.  We included patients who were living in Can Tho City with one of the 
following discharge diagnoses according to the coding of the International 
Classification of Diseases, 10th revision (ICD-10): unstable angina (I20.0), 
acute myocardial infarction (I21) or subsequent myocardial infarction (I22). 
We excluded patients (1) who were unable to communicate in Vietnamese; 
(2) who had cognitive impairment (with the score of the mini mental state 
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Tho City within one month after discharge. Each participant understood the 
study objective and voluntarily signed an informed consent form. We 
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Appendix B. Understanding items of the pre-final version of the BIPQ and BMQ in 




N = 16, n (%) 
Pilot patients 
N = 31, n (%) 
BIPQ 1 16 (100) 31 (100) 
BIPQ 2 16 (100) 30 (96.8) 
BIPQ 3 16 (100) 29 (93.5) 
BIPQ 4 16 (100) 31 (100) 
BIPQ 5 15 (93.8) 29 (93.5) 
BIPQ 6 16 (100) 29 (93.5) 
BIPQ 7 16 (100) 30 (96.8) 
BIPQ 8 16 (100) 29 (93.5) 
BIPQ 9 16 (100) 31 (100) 
Average of  
BIPQ items 
15.89 (99.3) 29.89 (96.4) 
BMQ 1 15 (93.8) 31 (100) 
BMQ 2 16 (100) 31 (100) 
BMQ 3 16 (100) 31 (100) 
BMQ 4 16 (100) 31 (100) 
BMQ 5 16 (100) 31 (100) 
BMQ 6 16 (100) 28 (90.3) 
BMQ 7 16 (100) 31 (100) 
BMQ 8 16 (100) 31 (100) 
BMQ 9 16 (100) 31 (100) 
BMQ 10 16 (100) 31 (100) 
BMQ 11 16 (100) 31 (100) 
BMQ 12 15 (93.8) 31 (100) 
BMQ 13 16 (100) 30 (96.8) 
BMQ 14 16 (100) 28 (90.3) 
BMQ 15 16 (100) 31 (100) 
BMQ 16 16 (100) 31 (100) 
BMQ 17 16 (100) 31 (100) 
BMQ 18 16 (100) 31 (100) 
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Appendix C. The BIPQ-V and BMQ-V 
 
Number Questionnaire item in Vietnamese 
The Vietnamese version of the Brief Illness Perception Questionnaire (BIPQ-V) 
BIPQ 1 Bệnh ảnh hưởng đến cuộc sống của bạn ở mức độ nào? 
BIPQ 2 Bạn nghĩ bệnh của bạn còn kéo dài bao lâu nữa? 
BIPQ 3 Bạn cảm thấy bạn có khả năng kiểm soát bệnh của bạn ở mức độ nào? 
BIPQ 4 Bạn nghĩ việc điều trị giúp ích cho bệnh của bạn ở mức độ nào? 
BIPQ 5 Bạn cảm nhận các triệu chứng bệnh của bạn ở mức độ nào? 
BIPQ 6 Bạn quan tâm về bệnh của bạn ở mức độ nào? 
BIPQ 7 Bạn cảm thấy bạn hiểu về bệnh của bạn rõ như thế nào? 
BIPQ 8 Bệnh ảnh hưởng đến cảm xúc của bạn ở mức độ nào? (ví dụ, nó có làm bạn tức giận, 
sợ hãi, bực bội hay chán nản) 
BIPQ 9 Vui lòng liệt kê theo trình tự mức độ quan trọng ba nguyên nhân mà bạn nghĩ gây ra 
bệnh của bạn. Các nguyên nhân quan trọng nhất là? 
The Vietnamese version of the Beliefs about Medicines (BMQ-V) 
BMQ 1 Sức khỏe của tôi hiện tại phụ thuộc vào thuốc.   
BMQ 2 Cuộc sống của tôi không thể không có thuốc. 
BMQ 3 Không có thuốc tôi sẽ cảm thấy rất không khỏe. 
BMQ 4 Sức khỏe của tôi trong tương lai sẽ phụ thuộc vào thuốc.  
BMQ 5 Thuốc bảo vệ tôi không tiến triển bệnh nặng hơn. 
BMQ 6 Phải uống thuốc làm tôi lo lắng. 
BMQ 7 Thỉnh thoảng tôi lo lắng về ảnh hưởng của thuốc khi sử dụng lâu dài. 
BMQ 8 Tôi vẫn chưa hiểu hết về các thuốc mình đang dùng. 
BMQ 9 Thuốc gây bất tiện cho cuộc sống của tôi. 
BMQ 10 Thỉnh thoảng tôi lo lắng trở nên quá phụ thuộc vào thuốc.  
BMQ 11 Bác sĩ sử dụng quá nhiều thuốc cho bệnh nhân. 
BMQ 12 Các phương thuốc dân gian trong tự nhiên an toàn hơn thuốc tân dược. 
BMQ 13 Bác sĩ đặt quá nhiều tin cậy vào thuốc. 
BMQ 14 Nếu bác sĩ có nhiều thời gian với bệnh nhân hơn, họ sẽ kê đơn ít thuốc hơn. 
BMQ 15 Những người đang dùng thuốc nên thỉnh thoảng tạm ngưng điều trị một thời gian 
ngắn. 
BMQ 16 Hầu hết các thuốc đều gây nghiện. 
BMQ 17 Thuốc có hại nhiều hơn lợi. 
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Abbreviations: BIPQ, Brief Illness Perception Questionnaire; BMQ, Beliefs about Medicines 
Questionnaire. 
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